RITODRINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ritodrine hydrochloride and what is the scope of patent protection?
Ritodrine hydrochloride
is the generic ingredient in three branded drugs marketed by Abraxis Pharm, Hospira, and Astrazeneca, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for ritodrine hydrochloride.
Summary for RITODRINE HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 7 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 10 |
| Patent Applications: | 779 |
| DailyMed Link: | RITODRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for RITODRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | Phase 3 |
| Assiut University | Phase 4 |
| Assiut University | N/A |
Medical Subject Heading (MeSH) Categories for RITODRINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for RITODRINE HYDROCHLORIDE
US Patents and Regulatory Information for RITODRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | RITODRINE HYDROCHLORIDE | ritodrine hydrochloride | INJECTABLE;INJECTION | 071188-001 | Jul 23, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER | ritodrine hydrochloride | INJECTABLE;INJECTION | 071438-001 | Jan 22, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | RITODRINE HYDROCHLORIDE | ritodrine hydrochloride | INJECTABLE;INJECTION | 071618-001 | Feb 28, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RITODRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
